跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Pradaxa - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Pradaxa
Approved
STANDARD
Pradaxa
Boehringer Ingelheim Pharma GmbH & Co. KG
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
cd53508e5e15fd28
Company
Boehringer Ingelheim Pharma GmbH & Co. KG
Type
Standard
Approval Details
Approval Id
cd53508e5e15fd28
Drug Approval Philippines Name
Pradaxa
Product Name
Pradaxa
Registration Number
DRP-7435
Brand Name
Pradaxa
Generic Name
Dabigatran Etexilate
Dosage Form
Capsule
Dosage Strength
75mg
Manufacturer
Boehringer Ingelheim Pharma GmbH & Co. KG
Importer
Boehringer Ingelheim (Philippines), Inc.
Company Detail Path
/organization/boehringer-ingelheim-pharma-gmbh-and-co-kg
Issuance Date
24 January 2024
Expiry Date
30 January 2029
Pharmacologic Category
Direct Thrombin Inhibitors
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
cd53508e5e15fd28
Type
Standard
Back to Philippines FDA Approvals